Back to Search
GARRETT BRODEUR, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1831119965Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
MD051368L(PA)
Pediatric Emergency Medicine (Pediatrics) Physician
Pediatrics — Pediatric Emergency Medicine
Code: 2080P0204X
MD051368L(PA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD051368L(PA)
Research & Publications (20)
Significance of intratumoral genetic heterogeneity in neuroblastomas.
PMID 11813176·Med Pediatr Oncol·2002
8-other
Biological aspects of neuroblastomas identified by mass screening in Quebec.
PMID 11464873·Med Pediatr Oncol·2001
4-observational
Meeting summary for Advances in Neuroblastoma Research--2000.
PMID 11107157·Med Pediatr Oncol·2000
7-preclinical
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
PMID 19401703·Br J Cancer·2009
8-other
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
PMID 19047290·J Clin Oncol·2009
8-other
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
PMID 19047291·J Clin Oncol·2009
8-other
Identification of ALK as a major familial neuroblastoma predisposition gene.
PMID 18724359·Nature·2008
8-other
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
PMID 18281664·J Clin Oncol·2008
4-observational
Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
PMID 17667943·Oncogene·2008
8-other
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
PMID 18505919·Mol Cancer Res·2008
8-other
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
PMID 18577749·J Natl Cancer Inst·2008
7-preclinical
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
PMID 16778177·Cancer Res·2006
8-other
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
PMID 16116152·J Clin Oncol·2005
3-trial
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
PMID 16116153·J Clin Oncol·2005
4-observational
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.
PMID 16267010·Cancer Res·2005
8-other
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
PMID 16314642·J Clin Oncol·2005
2-rct
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
PMID 15829979·Oncogene·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 CIVIC CENTER BLVD, CHILDREN'S HOSPITAL OF PHILADELPHIA - HEM/ONC
PHILADELPHIA, PA 19104 - Phone
- (215) 590-3535
Quick Facts
- NPI
- 1831119965
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile